Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Pharmacological interrogation of TrkA-mediated mechanisms in hippocampal-dependent memory consolidation.

Josephy-Hernandez S, Pirvulescu I, Maira M, Aboulkassim T, Wong TP, McKinney RA, Saragovi HU.

PLoS One. 2019 Jun 24;14(6):e0218036. doi: 10.1371/journal.pone.0218036. eCollection 2019.

2.

Vaccination with Tumor-Ganglioside Glycomimetics Activates a Selective Immunity that Affords Cancer Therapy.

Tong W, Maira M, Roychoudhury R, Galan A, Brahimi F, Gilbert M, Cunningham AM, Josephy S, Pirvulescu I, Moffett S, Saragovi HU.

Cell Chem Biol. 2019 Jul 18;26(7):1013-1026.e4. doi: 10.1016/j.chembiol.2019.03.018. Epub 2019 May 16.

PMID:
31105061
3.

The Paradoxical Signals of Two TrkC Receptor Isoforms Supports a Rationale for Novel Therapeutic Strategies in ALS.

Brahimi F, Maira M, Barcelona PF, Galan A, Aboulkassim T, Teske K, Rogers ML, Bertram L, Wang J, Yousefi M, Rush R, Fabian M, Cashman N, Saragovi HU.

PLoS One. 2016 Oct 3;11(10):e0162307. doi: 10.1371/journal.pone.0162307. eCollection 2016.

4.

Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors.

Vaughan L, Clarke PA, Barker K, Chanthery Y, Gustafson CW, Tucker E, Renshaw J, Raynaud F, Li X, Burke R, Jamin Y, Robinson SP, Pearson A, Maira M, Weiss WA, Workman P, Chesler L.

Oncotarget. 2016 Sep 6;7(36):57525-57544. doi: 10.18632/oncotarget.10544.

5.

Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology.

Tong W, Maira M, Gagnon M, Saragovi HU.

PLoS One. 2015 Aug 7;10(8):e0134255. doi: 10.1371/journal.pone.0134255. eCollection 2015.

6.

Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer.

Elfiky AA, Aziz SA, Conrad PJ, Siddiqui S, Hackl W, Maira M, Robert CL, Kluger HM.

J Transl Med. 2011 Aug 11;9:133. doi: 10.1186/1479-5876-9-133.

7.

Role for TGF-beta superfamily signaling in telencephalic GABAergic neuron development.

Maira M, Long JE, Lee AY, Rubenstein JL, Stifani S.

J Neurodev Disord. 2010 Mar;2(1):48-60. Epub 2009 Nov 27.

8.

Erratum to: Role for TGF-β superfamily signaling in telencephalic GABAergic neuron development.

Maira M, Long JE, Lee AY, Rubenstein JL, Stifani S.

J Neurodev Disord. 2010 Mar;2(1):47. doi: 10.1007/s11689-009-9040-9. No abstract available.

9.

Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.

Konstantinidou G, Bey EA, Rabellino A, Schuster K, Maira MS, Gazdar AF, Amici A, Boothman DA, Scaglioni PP.

Cancer Res. 2009 Oct 1;69(19):7644-52. doi: 10.1158/0008-5472.CAN-09-0823. Epub 2009 Sep 29.

10.

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.

Engelman JA, Chen L, Tan X, Crosby K, Guimaraes AR, Upadhyay R, Maira M, McNamara K, Perera SA, Song Y, Chirieac LR, Kaur R, Lightbown A, Simendinger J, Li T, Padera RF, García-Echeverría C, Weissleder R, Mahmood U, Cantley LC, Wong KK.

Nat Med. 2008 Dec;14(12):1351-6. doi: 10.1038/nm.1890. Epub 2008 Nov 30.

11.

Arx is a direct target of Dlx2 and thereby contributes to the tangential migration of GABAergic interneurons.

Colasante G, Collombat P, Raimondi V, Bonanomi D, Ferrai C, Maira M, Yoshikawa K, Mansouri A, Valtorta F, Rubenstein JL, Broccoli V.

J Neurosci. 2008 Oct 15;28(42):10674-86. doi: 10.1523/JNEUROSCI.1283-08.2008.

12.

NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.

Serra V, Markman B, Scaltriti M, Eichhorn PJ, Valero V, Guzman M, Botero ML, Llonch E, Atzori F, Di Cosimo S, Maira M, Garcia-Echeverria C, Parra JL, Arribas J, Baselga J.

Cancer Res. 2008 Oct 1;68(19):8022-30. doi: 10.1158/0008-5472.CAN-08-1385.

13.

Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.

O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.

Cancer Chemother Pharmacol. 2008 Nov;62(6):1045-54. doi: 10.1007/s00280-008-0695-9. Epub 2008 Feb 27.

PMID:
18301895
14.

Spatial heterogeneity of bacterial populations in monomictic Lake Estanya (Huesca, Spain).

Maira MA, Sebastian MA, Sergi RM, Elena GT, Amils R, Gaju N.

Microb Ecol. 2008 May;55(4):737-50.

PMID:
18080704
15.

Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.

Martens C, Bilodeau S, Maira M, Gauthier Y, Drouin J.

Mol Endocrinol. 2005 Apr;19(4):885-97. Epub 2004 Dec 9.

PMID:
15591535
16.

The T-box factor Tpit recruits SRC/p160 co-activators and mediates hormone action.

Maira M, Couture C, Le Martelot G, Pulichino AM, Bilodeau S, Drouin J.

J Biol Chem. 2003 Nov 21;278(47):46523-32. Epub 2003 Sep 11.

17.
18.

Opposite ability of pre-TCR and alpha beta TCR to induce apoptosis.

Steff AM, Trop S, Maira M, Drouin J, Hugo P.

J Immunol. 2001 Apr 15;166(8):5044-50.

19.
21.

Antagonism between Nur77 and glucocorticoid receptor for control of transcription.

Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P, Drouin J.

Mol Cell Biol. 1997 Oct;17(10):5952-9.

22.

Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells.

Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P, Drouin J.

Mol Cell Biol. 1997 Oct;17(10):5946-51.

23.

Mapping of the RNA-binding domain of the alfalfa mosaic virus movement protein.

Schoumacher F, Giovane C, Maira M, Poirson A, Godefroy-Colburn T, Berna A.

J Gen Virol. 1994 Nov;75 ( Pt 11):3199-202.

PMID:
7964629
24.

Physical therapy education in family practice residency programs.

Maira ML, Patton DD, Purvis JR.

Fam Med. 1994 Oct;26(9):576-8.

PMID:
7843507
25.

Binding of RNA by the alfalfa mosaic virus movement protein is biphasic.

Schoumacher F, Gagey MJ, Maira M, Stussi-Garaud C, Godefroy-Colburn T.

FEBS Lett. 1992 Aug 24;308(3):231-4.

26.

[Use of slow-release sodium diclofenac in patients with rheumatoid arthritis].

Zorzin L, Maira MG, Giobbio A, Capone M.

Clin Ter. 1985 Jul 31;114(2):105-10. Italian. No abstract available.

PMID:
4053529
27.

[Health examination of school children of a high socioeconomic level, a descriptive study].

de la Fuente M, Maira ME, Margozzini J, Prado M, Yentzen G, Bachellet M, Aguilera CP.

Rev Chil Pediatr. 1981 Nov-Dec;52(6):511-9. Spanish. No abstract available.

PMID:
7347865

Supplemental Content

Support Center